Bristol-Myers Squibb Co

BRM

Company Profile

  • Business description

    Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

  • Contact

    Route 206 and Province Line Road
    Princeton
    New JerseyNJ08543
    USA

    T: +1 609 252-4621

    E: [email protected]

    https://www.bms.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2026

    Employees

    32,500

Stocks News & Analysis

stocks

Reassuring organic growth for undervalued ASX share

Efficiency gains are starting to make their mark.
stocks

Big IPOs are enticing but are they good investments?

Historically, buzzy debuts have been painful for buyers.
stocks

This defensive ASX listed REIT offers a 5% yield

Solid outlook underpinned by rent uplifts and development pipeline.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,692.80143.80-1.63%
CAC 407,950.07130.67-1.62%
DAX 4024,865.00598.81-2.35%
Dow JONES (US)49,203.91106.850.22%
FTSE 10010,367.5885.10-0.81%
HKSE22,410.80430.82-1.89%
NASDAQ23,400.98478.22-2.00%
Nikkei 22556,436.653,007.56-5.06%
NZX 50 Index14,107.41139.84-0.98%
S&P 5007,111.1164.72-0.90%
S&P/ASX 2008,592.60137.80-1.58%
SSE Composite Index3,533.7943.82-1.22%

Market Movers